GWEP1415: An open label extension study to investigate the safety of cannabidiol (GWP42003-P; CBD) in children and adults with inadequately controlled Dravet or Lennox-Gastaut Syndromes

Grants and Contracts Details

StatusFinished
Effective start/end date9/15/15 → 4/23/20

Funding

  • GW Research Limited: $143,719.00